Logo image of CPAY

CORPAY INC (CPAY) Stock Fundamental Analysis

NYSE:CPAY - New York Stock Exchange, Inc. - US2199481068 - Common Stock - Currency: USD

316.59  +7.22 (+2.33%)

After market: 316.59 0 (0%)

Fundamental Rating

6

Overall CPAY gets a fundamental rating of 6 out of 10. We evaluated CPAY against 101 industry peers in the Financial Services industry. CPAY has an excellent profitability rating, but there are some minor concerns on its financial health. CPAY is not priced too expensively while it is growing strongly. Keep and eye on this one! These ratings could make CPAY a good candidate for growth investing.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

CPAY had positive earnings in the past year.
In the past year CPAY had a positive cash flow from operations.
In the past 5 years CPAY has always been profitable.
CPAY had a positive operating cash flow in each of the past 5 years.
CPAY Yearly Net Income VS EBIT VS OCF VS FCFCPAY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

1.2 Ratios

CPAY has a better Return On Assets (5.14%) than 74.26% of its industry peers.
Looking at the Return On Equity, with a value of 26.72%, CPAY belongs to the top of the industry, outperforming 90.10% of the companies in the same industry.
CPAY's Return On Invested Capital of 10.80% is amongst the best of the industry. CPAY outperforms 87.13% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CPAY is above the industry average of 7.67%.
Industry RankSector Rank
ROA 5.14%
ROE 26.72%
ROIC 10.8%
ROA(3y)6.24%
ROA(5y)6.25%
ROE(3y)33.21%
ROE(5y)29.98%
ROIC(3y)12.51%
ROIC(5y)11.72%
CPAY Yearly ROA, ROE, ROICCPAY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

With an excellent Profit Margin value of 25.17%, CPAY belongs to the best of the industry, outperforming 80.20% of the companies in the same industry.
In the last couple of years the Profit Margin of CPAY has declined.
The Operating Margin of CPAY (43.91%) is better than 81.19% of its industry peers.
In the last couple of years the Operating Margin of CPAY has remained more or less at the same level.
With an excellent Gross Margin value of 78.12%, CPAY belongs to the best of the industry, outperforming 85.15% of the companies in the same industry.
In the last couple of years the Gross Margin of CPAY has declined.
Industry RankSector Rank
OM 43.91%
PM (TTM) 25.17%
GM 78.12%
OM growth 3Y0.25%
OM growth 5Y-1.02%
PM growth 3Y-5.18%
PM growth 5Y-5.66%
GM growth 3YN/A
GM growth 5Y-4.82%
CPAY Yearly Profit, Operating, Gross MarginsCPAY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CPAY is still creating some value.
CPAY has less shares outstanding than it did 1 year ago.
CPAY has less shares outstanding than it did 5 years ago.
CPAY has a worse debt/assets ratio than last year.
CPAY Yearly Shares OutstandingCPAY Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
CPAY Yearly Total Debt VS Total AssetsCPAY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

An Altman-Z score of 2.02 indicates that CPAY is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.02, CPAY is in the better half of the industry, outperforming 74.26% of the companies in the same industry.
The Debt to FCF ratio of CPAY is 4.21, which is a neutral value as it means it would take CPAY, 4.21 years of fcf income to pay off all of its debts.
CPAY's Debt to FCF ratio of 4.21 is fine compared to the rest of the industry. CPAY outperforms 70.30% of its industry peers.
CPAY has a Debt/Equity ratio of 1.91. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 1.91, CPAY is not doing good in the industry: 64.36% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.91
Debt/FCF 4.21
Altman-Z 2.02
ROIC/WACC1.33
WACC8.14%
CPAY Yearly LT Debt VS Equity VS FCFCPAY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.3 Liquidity

CPAY has a Current Ratio of 1.12. This is a normal value and indicates that CPAY is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of CPAY (1.12) is comparable to the rest of the industry.
A Quick Ratio of 1.12 indicates that CPAY should not have too much problems paying its short term obligations.
CPAY has a Quick ratio of 1.12. This is comparable to the rest of the industry: CPAY outperforms 54.46% of its industry peers.
Industry RankSector Rank
Current Ratio 1.12
Quick Ratio 1.12
CPAY Yearly Current Assets VS Current LiabilitesCPAY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

7

3. Growth

3.1 Past

CPAY shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 13.77%, which is quite good.
The Earnings Per Share has been growing by 10.03% on average over the past years. This is quite good.
CPAY shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 9.22%.
Measured over the past years, CPAY shows a quite strong growth in Revenue. The Revenue has been growing by 8.45% on average per year.
EPS 1Y (TTM)13.77%
EPS 3Y12.9%
EPS 5Y10.03%
EPS Q2Q%12.75%
Revenue 1Y (TTM)9.22%
Revenue growth 3Y11.94%
Revenue growth 5Y8.45%
Sales Q2Q%12.95%

3.2 Future

Based on estimates for the next years, CPAY will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.01% on average per year.
CPAY is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.09% yearly.
EPS Next Y12.61%
EPS Next 2Y14.4%
EPS Next 3Y14.93%
EPS Next 5Y15.01%
Revenue Next Year11.03%
Revenue Next 2Y10.74%
Revenue Next 3Y10.43%
Revenue Next 5Y10.09%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
CPAY Yearly Revenue VS EstimatesCPAY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B 4B 5B
CPAY Yearly EPS VS EstimatesCPAY Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 10 20 30

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 15.83, the valuation of CPAY can be described as correct.
The rest of the industry has a similar Price/Earnings ratio as CPAY.
CPAY is valuated rather cheaply when we compare the Price/Earnings ratio to 27.11, which is the current average of the S&P500 Index.
CPAY is valuated correctly with a Price/Forward Earnings ratio of 12.72.
CPAY's Price/Forward Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 35.78, CPAY is valued rather cheaply.
Industry RankSector Rank
PE 15.83
Fwd PE 12.72
CPAY Price Earnings VS Forward Price EarningsCPAY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CPAY indicates a somewhat cheap valuation: CPAY is cheaper than 63.37% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, CPAY is valued a bit cheaper than 74.26% of the companies in the same industry.
Industry RankSector Rank
P/FCF 11.57
EV/EBITDA 11.88
CPAY Per share dataCPAY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 -40 -60

4.3 Compensation for Growth

CPAY's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
CPAY has a very decent profitability rating, which may justify a higher PE ratio.
CPAY's earnings are expected to grow with 14.93% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.26
PEG (5Y)1.58
EPS Next 2Y14.4%
EPS Next 3Y14.93%

0

5. Dividend

5.1 Amount

No dividends for CPAY!.
Industry RankSector Rank
Dividend Yield N/A

CORPAY INC

NYSE:CPAY (8/13/2025, 8:04:00 PM)

After market: 316.59 0 (0%)

316.59

+7.22 (+2.33%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)08-06 2025-08-06/amc
Earnings (Next)N/A N/A
Inst Owners97.31%
Inst Owner Change-0.97%
Ins Owners3.52%
Ins Owner Change5.17%
Market Cap22.32B
Analysts81.82
Price Target399.44 (26.17%)
Short Float %2.92%
Short Ratio4.19
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-1.91%
Min EPS beat(2)-2.03%
Max EPS beat(2)-1.79%
EPS beat(4)0
Avg EPS beat(4)-1.76%
Min EPS beat(4)-2.03%
Max EPS beat(4)-1.45%
EPS beat(8)0
Avg EPS beat(8)-1.85%
EPS beat(12)2
Avg EPS beat(12)-1.27%
EPS beat(16)5
Avg EPS beat(16)-0.4%
Revenue beat(2)0
Avg Revenue beat(2)-2.27%
Min Revenue beat(2)-2.93%
Max Revenue beat(2)-1.6%
Revenue beat(4)0
Avg Revenue beat(4)-2.43%
Min Revenue beat(4)-3.5%
Max Revenue beat(4)-1.6%
Revenue beat(8)0
Avg Revenue beat(8)-2.73%
Revenue beat(12)1
Avg Revenue beat(12)-2.06%
Revenue beat(16)5
Avg Revenue beat(16)-1.05%
PT rev (1m)-0.29%
PT rev (3m)-1.16%
EPS NQ rev (1m)0.61%
EPS NQ rev (3m)0.16%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.37%
Revenue NQ rev (1m)0.68%
Revenue NQ rev (3m)1.03%
Revenue NY rev (1m)0.31%
Revenue NY rev (3m)0.71%
Valuation
Industry RankSector Rank
PE 15.83
Fwd PE 12.72
P/S 5.35
P/FCF 11.57
P/OCF 10.55
P/B 5.68
P/tB N/A
EV/EBITDA 11.88
EPS(TTM)20
EY6.32%
EPS(NY)24.88
Fwd EY7.86%
FCF(TTM)27.36
FCFY8.64%
OCF(TTM)30.01
OCFY9.48%
SpS59.18
BVpS55.73
TBVpS-67.78
PEG (NY)1.26
PEG (5Y)1.58
Profitability
Industry RankSector Rank
ROA 5.14%
ROE 26.72%
ROCE 16.97%
ROIC 10.8%
ROICexc 13.11%
ROICexgc 87.43%
OM 43.91%
PM (TTM) 25.17%
GM 78.12%
FCFM 46.23%
ROA(3y)6.24%
ROA(5y)6.25%
ROE(3y)33.21%
ROE(5y)29.98%
ROIC(3y)12.51%
ROIC(5y)11.72%
ROICexc(3y)14.83%
ROICexc(5y)13.92%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)18.71%
ROCE(5y)16.98%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y1.1%
ROICexc growth 5Y0.59%
OM growth 3Y0.25%
OM growth 5Y-1.02%
PM growth 3Y-5.18%
PM growth 5Y-5.66%
GM growth 3YN/A
GM growth 5Y-4.82%
F-Score7
Asset Turnover0.2
Health
Industry RankSector Rank
Debt/Equity 1.91
Debt/FCF 4.21
Debt/EBITDA 3.42
Cap/Depr 51.24%
Cap/Sales 4.49%
Interest Coverage 3.69
Cash Conversion 96.28%
Profit Quality 183.69%
Current Ratio 1.12
Quick Ratio 1.12
Altman-Z 2.02
F-Score7
WACC8.14%
ROIC/WACC1.33
Cap/Depr(3y)47.52%
Cap/Depr(5y)42.51%
Cap/Sales(3y)4.31%
Cap/Sales(5y)4.03%
Profit Quality(3y)145.81%
Profit Quality(5y)152.95%
High Growth Momentum
Growth
EPS 1Y (TTM)13.77%
EPS 3Y12.9%
EPS 5Y10.03%
EPS Q2Q%12.75%
EPS Next Y12.61%
EPS Next 2Y14.4%
EPS Next 3Y14.93%
EPS Next 5Y15.01%
Revenue 1Y (TTM)9.22%
Revenue growth 3Y11.94%
Revenue growth 5Y8.45%
Sales Q2Q%12.95%
Revenue Next Year11.03%
Revenue Next 2Y10.74%
Revenue Next 3Y10.43%
Revenue Next 5Y10.09%
EBIT growth 1Y7.76%
EBIT growth 3Y12.22%
EBIT growth 5Y7.35%
EBIT Next Year33.23%
EBIT Next 3Y17.77%
EBIT Next 5Y15.62%
FCF growth 1Y40.15%
FCF growth 3Y17.6%
FCF growth 5Y10.19%
OCF growth 1Y37.41%
OCF growth 3Y17.47%
OCF growth 5Y10.8%